Tag: Emirates Drug Establishment
UAE approves Jascayd for pulmonary fibrosis treatment
The Emirates Drug Establishment (EDE) has granted regulatory approval for Jascayd (nerandomilast), an innovative treatment for adult patients with Idiopathic Pulmonary Fibrosis (IPF) and...
EDE, Novo Nordisk sign MoU to advance UAE pharma manufacturing
The Emirates Drug Establishment (EDE) has signed a memorandum of understanding (MoU) with Novo Nordisk, the global healthcare company, to enhance cooperation in pharmaceutical...
UAE approves oral Wegovy semaglutide for weight management
The Emirates Drug Establishment (EDE) has approved Wegovy (semaglutide), an oral once-daily treatment for long-term weight management in adults living with obesity or overweight...
EDE launches task force to secure UAE pharmaceutical supply
The Emirates Drug Establishment (EDE) has announced the formation of a strategic task force comprising 16 partners across the UAE’s pharmaceutical and logistics ecosystem....
Emirates Drug Establishment reassures secure medicine reserves
The UAE Minister of State and Chairman of the Board of Directors of the Emirates Drug Establishment, HE Saeed bin Mubarak Al Hajeri, has...
EDE unveils Organ on Chip, inks MoUs at WHX 2026
The Emirates Drug Establishment signed two strategic memorandums of understanding (MoU) at World Health Expo 2026 in Dubai, to advance sustainability, regulatory innovation and...
EDE showcases groundbreaking medical projects at WHX 2026
Saeed bin Mubarak Al Hajeri, Minister of State and Chairman of the Board of Directors of the Emirates Drug Establishment, has launched the Emirates...
UAE approves Itvisma gene therapy for older SMA patients
The UAE’s Emirates Drug Establishment (EDE) has approved Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular...
